Jay L. Pomerantz

Partner at Fenwick & West LLP

Jay L. Pomerantz

Jay L. Pomerantz

Partner at Fenwick & West LLP

Biography

Jay Pomerantz focuses his practice on representing technology companies and their directors and officers in securities class actions; derivative litigation; internal investigations; audit and board committee representations; SEC and regulatory matters; and corporate governance issues.

Jay has extensive experience litigating complex matters before federal and state courts, and representing companies, board committees and directors and officers in internal investigations and regulatory matters. He has represented audit and board committees of numerous companies with substantial China operations, as well as the officers and employees of these companies, in internal and regulatory investigations related to the Foreign Corrupt Practices Act (FCPA), revenue recognition and related accounting issues. Jay has also represented numerous biotech companies and their directors and officers in connection with securities class actions, derivative suits, and SEC regulatory proceedings. In 2013, Fenwick’s Securities Litigation team was named “Securities Litigation Department of the Year” by The Recorder over 20 other California firms.

Recent matters include internal investigations related to stock option pricing issues; defending companies and their directors and officers in securities class actions and derivative suits; conducting internal investigations for audit, compensation and other board committees related to accounting, FCPA, corporate governance and Sarbanes-Oxley issues; representing companies and individuals in SEC regulatory matters and defending against insider trading claims; and advising on corporate governance and D&O liability insurance issues. He has represented clients in numerous technology sectors, including biotech, semiconductor, software, digital media, Internet and Internet security, biometrics and telecommunications.

Representative Experience

Securities Class Actions and Shareholder Derivative Litigation

* Equinix, Inc. and its directors and officers in stock option derivative action filed in California state court; in June 2008, the court granted Equinix's motion to dismiss the complaint without leave to amend
* Numerous directors and officers in securities litigations and derivative suits arising from stock option pricing issues
* Bay Area biopharmaceutical company and its directors and officers in securities class action and derivative action
* Biotechnology Industry Organization (BIO) as amicus curiae in appeal to California Appellate court of In re Gilead Sciences, Inc. Derivative Litigation
* Tech issuer in securities fraud action in federal court in Colorado; plaintiff voluntarily dismissed action while motion to dismiss was pending
* Bay Area biotech company in securities class action in which plaintiff voluntarily dismissed the litigation at the outset
* Former senior FDA officials and advisors as witnesses in securities class action related to FDA approval process
* Directors, officers and employees of Calpine Corporation in federal securities class action, derivative suits, ERISA class action and state court Section 11 securities class action related to California energy crisis
* Directors of Chalone Wine Group in class action litigation alleging breaches of fiduciary duty in connection with the sale of Chalone to Diageo
* Former CFO of a semiconductor software company in securities class action, derivative suit, other related litigation and SEC investigation arising from financial restatement
* Several tech and biotech companies in the IPO laddering securities class actions in federal court in New York and IPO laddering Section 16(b) actions in federal court in Seattle
* NorthPoint Communications Group and several former NorthPoint officers and directors in securities class action arising from the company's revision of its quarterly results
* drkoop.com and its directors and officers in securities class action, derivative suit and related actions arising from the company's receipt of a "going-concern" opinion
* CEO of a software company in numerous actions arising from financial restatement

Audit Committee and Other Board Committee or Investigative Representations

* Special board committee of late-stage private company in investigation related to FCPA and stock option issues
* Officers and employees of company with substantial China operations in FCPA and revenue recognition investigations
* Numerous public companies in connection with accounting restatements and related issues
* Board committees and directors and officers—internal investigations of stock option pricing issues
* Audit Committee of public software company—internal investigation of Sarbanes-Oxley issues
* Audit Committee of private internet security software company—internal investigation of allegations by former senior executive
* Audit Committee of public semiconductor company—internal investigation of revenue-timing issues resulting in financial restatement
* Audit Committee of public semiconductor company—internal investigations of financial restatement and executive compensation/internal controls
* Audit Committee of public software company—internal investigation of revenue recognition issues resulting in financial restatement
* Compensation Committee of private tech company—advice on corporate governance issues

Regulatory

* Companies and directors and officers in connection with SEC investigations related to financial restatements, revenue recognition and other accounting items, as well as internal control and corporate governance issues
* Individuals in connection with DOJ investigation related to FCPA issues
* Numerous individuals in SEC insider trading investigations related to trading in tech stocks
* Senior officer of a public biotech company in an SEC insider trading investigation related to company's disclosure of clinical trial results
* Bay Area biopharmaceutical company in connection with short-selling activities by a brokerage house specializing in selling research on biotech companies
* CFO of internet retailer in connection with internal and SEC investigation of accounting practices
* Bay Area biopharmaceutical company in SEC proceeding regarding IPO laddering issues
* Representation involving SEC, DOJ and internal investigations related to Krispy Kreme Donuts
* Several audit committees of semiconductor and software companies in connection with SEC investigations of financial restatements, whistleblower allegations and alleged insider trading
* International investment bank and several of its officers and employees in connection with SEC and DOJ investigations of the NASDAQ stock market and related class action litigation

Overview
RelSci Relationships

797

Number of Boards

1

Contact Data
Trying to get in touch with Jay L. Pomerantz? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Relationships
RelSci Relationships are individuals Jay L. Pomerantz likely has professional access to. A relationship does not necessarily indicate a personal connection.

Partner at Fenwick & West LLP

Relationship likelihood: Strong

Chair, Antitrust & Unfair Competition at Fenwick & West LLP

Relationship likelihood: Strong

Co-Chair, Mergers & Acquisitions at Fenwick & West LLP

Relationship likelihood: Strong

Partner at Fenwick & West LLP

Relationship likelihood: Strong

Partner at Orrick, Herrington & Sutcliffe LLP

Relationship likelihood: Strong

Partner at Fenwick & West LLP

Relationship likelihood: Strong

Former Co-Chair, Securities & Corporate Finance at Fenwick & West LLP

Relationship likelihood: Strong

Chair, Securities Litigation Group at Fenwick & West LLP

Relationship likelihood: Strong

Managing Partner at Fenwick & West LLP

Relationship likelihood: Strong

Partner at Fenwick & West LLP

Relationship likelihood: Strong

Paths to Jay L. Pomerantz
Potential Connections via
Relationship Science
You
Jay L. Pomerantz
Partner at Fenwick & West LLP
Education
JD, Order of the Coif
Class of 1991

Stanford began offering a curriculum in legal studies in 1893, when the university engaged its first two law professors. One was Benjamin Harrison, former President of the United States, who delivered a landmark series of lectures on the Constitution. The other was Nathan Abbott, who served as head of the nascent law program. Abbott assembled a small faculty to which he imparted a standard of rigor and excellence that endures to this day.In an effort to acknowledge the emerging professional nature of the department, Stanford's Board of Trustees passed a resolution in 1908 to substitute the term 'law school' for 'law department,' though technically the law program remained a department within the university.The law school was at the forefront of efforts to institute the California Bar exam, which was added to the requirements to practice law in California in 1919. The law school was accredited by the American Bar Association in 1923, the year the ABA began certifying law schools.

BA

The University of California, Santa Cruz, has earned international distinction as a university with high-impact research and an uncommon commitment to teaching and public service. A campus with world-class facilities and one of the most visually spectacular settings in higher education, UC Santa Cruz provides unparalleled opportunities for students to learn through hands-on experience. A commitment to environmental stewardship and community engagement are also central to UCSC's core values.

Career History
Partner
Current

Fenwick & West LLP is a national law firm that provides comprehensive legal services to technology and life sciences clients of national and international prominence. The company's practice areas include antitrust and unfair competition, appellate, complex business litigation, copyright, corporate and securities, employment & labor, executive compensation & benefits, intellectual property and IP litigation. It offers legal advisory services in areas such as mergers and acquisitions, patent prosecution, privacy and information security. Fenwick & West was founded in 1972 and is headquartered in Mountain View, CA.

Boards & Committees
Co-Chair, Hiring Committee
Current

Fenwick & West LLP is a national law firm that provides comprehensive legal services to technology and life sciences clients of national and international prominence. The company's practice areas include antitrust and unfair competition, appellate, complex business litigation, copyright, corporate and securities, employment & labor, executive compensation & benefits, intellectual property and IP litigation. It offers legal advisory services in areas such as mergers and acquisitions, patent prosecution, privacy and information security. Fenwick & West was founded in 1972 and is headquartered in Mountain View, CA.

Political Donations
$1,000
2008

Former President of United States

Transactions
Details Hidden

SentinelOne, Inc. issued USD Common Stock

Details Hidden

SAP SE purchases SuccessFactors, Inc.

Details Hidden

HP, Inc. purchases ArcSight, Inc.

Other Affiliations

Jay L. Pomerantz is affiliated with Fenwick & West LLP, Fenwick & West LLP

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Jay L. Pomerantz. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Jay L. Pomerantz's profile does not indicate a business or promotional relationship of any kind between RelSci and Jay L. Pomerantz.